Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Eli Lilly and Company
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
University Health Network, Toronto
M.D. Anderson Cancer Center
UMC Utrecht
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
Fluidx Medical Technology, Inc.
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Emory University
Eastern Cooperative Oncology Group
Eisai Inc.
Roswell Park Cancer Institute
USWM, LLC (dba US WorldMeds)
Dana-Farber Cancer Institute
Institute of Cancer Research, United Kingdom
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
NRG Oncology
National Cancer Institute (NCI)
Centre Leon Berard
Children's Oncology Group
USWM, LLC (dba US WorldMeds)
H. Lee Moffitt Cancer Center and Research Institute
Deciphera Pharmaceuticals, LLC